Streptavidin, PE conjugated/tagged from Invitrogen

...esigned for RNA aptamer screening and binding opti...raflo microfluidic on-chip synthesis platform. The...hensive DNA/RNA Aptamer Microarray Service. Prob...ay contains greater than 1500 known aptamer sequen...

...esigned for RNA aptamer screening and binding opti...raflo microfluidic on-chip synthesis platform. Tho...synthesized on-chip and LC Sciences can provide as...rrays are available as part of our comprehensive D...

...l glutathione-S-transferase (GST) is commonly used.... coli (1). The GSTTag sequence has been reported ...lubility of its fusion partners. When expressed in...oteins can be purified with immobilized glutathion...

...em Cell Kit with Medium High quality ready-to-use ...th optimized base medium for growth and lineage co...enerated from E18 fetal rat brain in the format yo...progenitor cells, neurons, astrocytes and oligoden...

Biology Products:

Standard 2'-OMe RNA Aptamer Microarray from LC Sciences Custom 2'-F RNA Aptamer Microarray from LC Sciences pET GST Fusion System 41 plus Competent Cells from Novagen NeuroCyte - Rat Neural Stem Cell Kit from Orion BioSolutions, Inc.

(Date:11/6/2009)..., FAIRFAX, Va.Registration is now open for the So...Interventional Oncology (IO) Therapies" Webinar, w...us and transcatheter treatment of liver tumors, ki...s a national organization of physicians, scientist...roving public health through pioneering advances i...

(Date:11/6/2009)..., DETROIT, Nov. 6 Auburn Hill...LC (LEID) will be installing its locker system and...) (BACS) at the U.S. Department of Health and Huma...sed in Bethesda, MD. The locker system will suppo...le for protecting our nation,s medical research ag...

(Date:11/5/2009)..., New Haven, Conn.Researchers at Yale University ...ncing the body,s immune response to HIV and HIV-in... Their findings, published online in the Journal ...ovel therapeutic approaches for these diseases. ,...cule targeting HIV" (ARM-H) and "antibody-recruiti...

Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2 New synthetic molecules trigger immune response to HIV and prostate cancer 2 Making Obese Mice Slim Without Diet or Exercise 47823 1 Making Obese Mice Slim Without Diet or Exercise 47823 2 Making Obese Mice Slim Without Diet or Exercise 47823 3 Feeding Feelings 3A Survey Reveals Americans Are Turning to Junk Food When Stressed 47820 1 Feeding Feelings 3A Survey Reveals Americans Are Turning to Junk Food When Stressed 47820 2 Feeding Feelings 3A Survey Reveals Americans Are Turning to Junk Food When Stressed 47820 3 Feeding Feelings 3A Survey Reveals Americans Are Turning to Junk Food When Stressed 47820 4 Feeding Feelings 3A Survey Reveals Americans Are Turning to Junk Food When Stressed 47820 5 Definitive Outcomes of Radiofrequency Ablation for Barretts Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting fo 4532 1 Definitive Outcomes of Radiofrequency Ablation for Barretts Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting fo 4532 2 Definitive Outcomes of Radiofrequency Ablation for Barretts Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting fo 4532 3 Definitive Outcomes of Radiofrequency Ablation for Barretts Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting fo 4532 4

[1] Society of Interventional Radiology hosts oncology therapies Webinar, offers resources [0] National Institutes of Health Secures Armory with Patent-Pending Technology [1] New synthetic molecules trigger immune response to HIV and prostate cancer

...ith those of the avian virus that have also infect...netic changes required for pandemic strains of bir...ue of the journal Nature, illustrates the genetic ...s to adapt to easily recognize the receptors that ...d two changes that are important," says Yoshihiro ...

...g parts out of cells and putting them into systems...ety of medical uses. At the annual meeting of the ...ancisco, Stanford engineering Professor James Swar...in synthesis, including production of versatile, n...ucks for a new class of potentially more effective...

...ssible new cancer drug suggests that it may prove ...hemotherapeutic drugs. , Dr David Huang, Dr Andrew...HI,s cancer research divisions have been assessing...s developed by US-based healthcare company, Abbott...ve a limited lifespan. They die when they are dama...

Other Biology News:Scientists find mutations that let bird flu adapt to humans 2 Engineer ramps up protein production, develops versatile viral spheres 2 Engineer ramps up protein production, develops versatile viral spheres 3 Hope for a more effective and less toxic cancer drug 2

Scientists find mutations that let bird flu adapt to humans Engineer ramps up protein production, develops versatile viral spheres Hope for a more effective and less toxic cancer drug

(Date:11/6/2009)...HAYWARD, Calif., Nov. 6 Intarcia T...y on its ITCA 650 (DUROS® continuous delivery... diabetes at the Ninth Annual Diabetes Technology .../www.newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO...natide Via ITCA 650 Lowers Plasma Glucose, HbA1c a...

(Date:11/5/2009)...WELLINGTON, Colo., Nov. 5 The enda...wns in the western U.S. This rare carnivore feeds...eptible to plague and often entire population die-... Service (FWS) has implemented a ferret breeding p...rets into their formerly native habitat. Unfortun...

(Date:11/5/2009)...Conference Call on Thursday, November 5, 2009 at 4...UVER Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Pha...(NASDAQ: OGXI ) today reported unaudited financia...ded September 30, 2009 and reviewed the Company,s ...e following consolidated results reflect the opera...

(Date:11/5/2009)...FORT WORTH, Texas, Nov. 5 /PRNewswire-FirstCall/ -...ounced today that it has entered into a Letter of ...f Virtual Health Technologies, Inc. (OTC Bulletin ...d $1,000,000 in cash and debt, 4,000,000 shares of...ed by WNDM on the Veriscrip technology being acqui...

Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2 Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3 Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4 Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5 Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2 OncoGenex Reports Third Quarter 2009 Financial Results 2 OncoGenex Reports Third Quarter 2009 Financial Results 3 OncoGenex Reports Third Quarter 2009 Financial Results 4 OncoGenex Reports Third Quarter 2009 Financial Results 5 OncoGenex Reports Third Quarter 2009 Financial Results 6 OncoGenex Reports Third Quarter 2009 Financial Results 7 OncoGenex Reports Third Quarter 2009 Financial Results 8 OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2 OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3

[0] Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting [0] Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret [0] OncoGenex Reports Third Quarter 2009 Financial Results [0] OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock